These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 27988039)

  • 1. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy.
    Broch K; Murbræch K; Andreassen AK; Hopp E; Aakhus S; Gullestad L
    Am J Cardiol; 2015 Sep; 116(6):952-9. PubMed ID: 26233575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
    Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
    Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of and Frequency of Mortality, Left Ventricular Assist Device Implantation, Ventricular Arrhythmias, and Heart Transplantation in Patients With Familial Versus Nonfamilial Idiopathic Dilated Cardiomyopathy.
    Rao RA; Kozaily E; Jawaid O; Sabra M; El-Am EA; Chaaya RGB; Woiewodski L; Elsemesmani H; Ramchandani J; Shah C; Guglin M; Das MK
    Am J Cardiol; 2022 Sep; 179():83-89. PubMed ID: 35909017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
    Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
    Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure.
    Horii T; Suma H; Isomura T; Nomura F; Hoshino J
    Ann Thorac Surg; 2006 Oct; 82(4):1349-54; discussion 1354-5. PubMed ID: 16996932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
    Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
    J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction.
    Dandamudi G; Rampurwala AY; Mahenthiran J; Miller JM; Das MK
    Heart Rhythm; 2008 Aug; 5(8):1111-4. PubMed ID: 18675220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Kitaoka H; Takata J; Doi Y; Sugiura T
    Cardiovasc Ultrasound; 2015 Mar; 13():14. PubMed ID: 25880063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional heterogeneity of systolic dysfunction is associated with ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy and narrow QRS complex.
    Matsumoto K; Tanaka H; Tatsumi K; Kaneko A; Tsuji T; Ryo K; Kawai H; Hirata K
    Echocardiography; 2012 Nov; 29(10):1201-10. PubMed ID: 22862431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices.
    Kusa S; Miller MA; Whang W; Enomoto Y; Panizo JG; Iwasawa J; Choudry S; Pinney S; Gomes A; Langan N; Koruth JS; d'Avila A; Reddy VY; Dukkipati SR
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.